State Of Wisconsin Investment Board Corbus Pharmaceuticals Holdings, Inc. Transaction History

State Of Wisconsin Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$0.94 - $1.89 $86,198 - $173,313	-91,700 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$3.44 - $7.21 $9,288 - $19,467	2,700 Added 3.03%	91,700 $480,000
Q3 2019 Nov 12, 2019	BUY	$4.87 - $7.08 $79,381 - $115,404	16,300 Added 22.42%	89,000 $433,000
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $10,560 - $12,480	1,600 Added 2.25%	72,700 $504,000
Q1 2019 May 13, 2019	BUY	$5.76 - $8.95 $114,624 - $178,105	19,900 Added 38.87%	71,100 $494,000
Q4 2018 Feb 11, 2019	BUY	$5.26 - $7.97 $100,992 - $153,024	19,200 Added 60.0%	51,200 $299,000
Q3 2017 Nov 01, 2017	BUY	$5.75 - $7.75 $184,000 - $248,000	32,000	32,000 $229,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.